<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="pcn570125" xml:lang="en" article-type="case-study"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PCN Rep</journal-id><journal-id journal-id-type="iso-abbrev">PCN Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2769-2558</journal-id><journal-id journal-id-type="publisher-id">PCN5</journal-id><journal-title-group><journal-title>PCN Reports: Psychiatry and Clinical Neurosciences</journal-title></journal-title-group><issn pub-type="epub">2769-2558</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400724</article-id><article-id pub-id-type="pmc">PMC12092235</article-id><article-id pub-id-type="doi">10.1002/pcn5.70125</article-id><article-id pub-id-type="publisher-id">PCN570125</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>A case of late&#x02010;onset psychosis secondary to traumatic brain injury difficult to differentiate from delirium</article-title><alt-title alt-title-type="right-running-head">LATE PSYCHOSIS AFTER TRAUMATIC BRAIN INJURY</alt-title><alt-title alt-title-type="left-running-head">KATO <sc>et al.</sc>
</alt-title></title-group><contrib-group><contrib id="pcn570125-cr-0001" contrib-type="author" corresp="yes"><name><surname>Kato</surname><given-names>Tomonobu</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9508-0714</contrib-id><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcn570125-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>TomonobuKato@keio.jp</email></address></contrib><contrib id="pcn570125-cr-0002" contrib-type="author"><name><surname>Tsujii</surname><given-names>Takashi</given-names></name><degrees>MD</degrees><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcn570125-cr-0003" contrib-type="author"><name><surname>Kida</surname><given-names>Hisashi</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7712-1105</contrib-id><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcn570125-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="pcn570125-cr-0004" contrib-type="author"><name><surname>Mochizuki</surname><given-names>Daiki</given-names></name><degrees>MD</degrees><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcn570125-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pcn570125-cr-0005" contrib-type="author"><name><surname>Nikkuni</surname><given-names>Shigeru</given-names></name><degrees>MD, PhD</degrees><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcn570125-cr-0006" contrib-type="author"><name><surname>Sakuma</surname><given-names>Kei</given-names></name><degrees>MD, PhD</degrees><xref rid="pcn570125-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="pcn570125-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neuropsychiatry</named-content>
<institution>Asaka Hospital</institution>
<city>Koriyama</city>
<named-content content-type="country-part">Fukushima</named-content>
<country country="JP">Japan</country>
</aff><aff id="pcn570125-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Neuropsychiatry</named-content>
<institution>Keio University School of Medicine</institution>
<city>Shinjuku</city>
<named-content content-type="country-part">Tokyo</named-content>
<country country="JP">Japan</country>
</aff><aff id="pcn570125-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>Tokyo Adachi Hospital</institution>
<city>Adachi</city>
<named-content content-type="country-part">Tokyo</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold> Tomonobu Kato, MD, PhD, Department of Neuropsychiatry, Asaka Hospital, 45 Kyotan, Sasagawa, Asakamachi, Koriyama, Fukushima 963&#x02010;0198, Japan.<break/>
Email: <email>TomonobuKato@keio.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>4</volume><issue seq="57">2</issue><issue-id pub-id-type="doi">10.1002/pcn5.v4.2</issue-id><elocation-id>e70125</elocation-id><history>
<date date-type="rev-recd"><day>03</day><month>5</month><year>2025</year></date>
<date date-type="received"><day>15</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Psychiatry and Clinical Neurosciences Reports</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PCN5-4-e70125.pdf"/><abstract><title>Abstract</title><sec id="pcn570125-sec-0010"><title>Background</title><p>Traumatic brain injury (TBI) is a brain injury caused by external forces and has a prevalence of 432 cases (95% uncertainty interval [UI]: 413&#x02013;452) per 100,000 people in Japan. Previous studies have indicated that TBI is associated with numerous psychiatric disorders, including psychosis.</p></sec><sec id="pcn570125-sec-0020"><title>Case Presentation</title><p>A 70&#x02010;year&#x02010;old male with a history of diabetes, bipolar disorder, and TBI sustained at the age of 51 years presented with late&#x02010;onset psychotic symptoms. This case highlights the delirium&#x02010;like fluctuating nature of psychotic symptoms and their successful management with risperidone.</p></sec><sec id="pcn570125-sec-0030"><title>Conclusion</title><p>Late&#x02010;onset psychotic disorders due to TBI can emerge long after initial injury and require careful and continuous monitoring.</p></sec></abstract><abstract abstract-type="graphical"><p>Traumatic brain injury (TBI) causes psychotic disorders to occur in a delayed&#x02010;onset form in certain cases. In this report, we present a case of psychotic disorders due to TBI with a sudden delirium&#x02010;like onset nearly 20 years after the traumatic injury, posing significant challenges for differential diagnosis.<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="PCN5-4-e70125-g002.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group><kwd id="pcn570125-kwd-0001">delirium</kwd><kwd id="pcn570125-kwd-0002">psychiatric disorder</kwd><kwd id="pcn570125-kwd-0003">psychosis secondary to traumatic brain injury</kwd><kwd id="pcn570125-kwd-0004">seizure</kwd><kwd id="pcn570125-kwd-0005">traumatic brain injury</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="4"/><word-count count="2220"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:21.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="pcn570125-cit-0018">
<string-name>
<surname>Kato</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsujii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kida</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mochizuki</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nikkuni</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sakuma</surname>
<given-names>K</given-names>
</string-name>. <article-title>A case of late&#x02010;onset psychosis secondary to traumatic brain injury difficult to differentiate from delirium</article-title>. <source>Psychiatry Clin Neurosci Rep</source>. <year>2025</year>;<volume>4</volume>:<elocation-id>e70125</elocation-id>. <pub-id pub-id-type="doi">10.1002/pcn5.70125</pub-id>
</mixed-citation>
</p></notes></front><body><sec sec-type="background" id="pcn570125-sec-0040"><title>BACKGROUND</title><p>Traumatic brain injury (TBI) is an injury to the brain caused by an external force. Its prevalence is estimated at 599 (95% uncertainty interval [UI]: 573&#x02013;627) cases per 100,000 people worldwide and 432 (95% UI: 413&#x02013;452) in Japan.<xref rid="pcn570125-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> It results in various neurobehavioral sequelae, such as memory deficits, aggression, apathy, headaches, and seizures.<xref rid="pcn570125-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> It is also associated with various psychiatric conditions. The reported prevalence of schizophrenia&#x02010;like psychosis following TBI ranges from 1% to 9%,<xref rid="pcn570125-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="pcn570125-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> while mood disorders occur in 6%&#x02013;77% of cases, anxiety disorders in 11%&#x02013;70%, and challenging behaviors in 11%&#x02013;90%.<xref rid="pcn570125-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="pcn570125-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="pcn570125-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="pcn570125-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> The onset of psychosis after TBI follows a bimodal distribution and can be classified as early&#x02010;onset and late&#x02010;onset types. A case series reported that 38% of patients developed psychosis within the first year after sustaining a TBI (early onset), while 36% experienced psychosis after 5 years (late onset), with a mean latency of 3.6 years. The sample consisted of 56 men and eight women.<xref rid="pcn570125-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="pcn570125-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Late&#x02010;onset psychotic disorders due to TBI (PDTBI) often occur in older adults.<xref rid="pcn570125-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> However, in general, late&#x02010;onset psychosis is associated with a higher risk of adverse drug reactions compared to early&#x02010;onset psychosis.<xref rid="pcn570125-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Additionally, it is often misdiagnosed as schizophrenia<xref rid="pcn570125-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> despite having distinct symptomatic features, such as a lower likelihood of negative symptoms and a higher likelihood of positive findings on computed tomography, MRI, or electroencephalography (EEG).<xref rid="pcn570125-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Therefore, accurate diagnosis and appropriate management are essential.</p><p>Here, we present a case of late&#x02010;onset PDTBI that initially manifested as delirium. The patient presented with psychotic symptoms at night, which worsened over a few days and disturbed the sense of time. Memory of the symptoms was preserved, and the patient was diagnosed with late&#x02010;onset PDTBI but not delirium.</p></sec><sec id="pcn570125-sec-0050"><title>CASE PRESENTATION</title><p>The patient was a 70&#x02010;year&#x02010;old male patient with well&#x02010;controlled diabetes and bipolar disorder. He also had a family history of bipolar disorder, and his older brother was affected. At the age of 51, he had sustained a skull fracture, resulting in TBI in the left frontal and temporal lobes (Figure <xref rid="pcn570125-fig-0001" ref-type="fig">1</xref>, left). Since then, he has experienced recurrent epileptic seizures, although the last recorded seizure occurred at the age of 53 years. Cognitive impairment, likely related to trauma, was noted, with a Mini&#x02010;Mental State Examination (MMSE) score of 21 at 60 years of age. However, there was no significant progression, with an MMSE score of 22 at 4 months before hospitalization. One month before hospitalization, the patient experienced mood depression. Around the same time, he contracted COVID&#x02010;19, leading to frequent absences from daycare services. One week prior to hospitalization, the patient exhibited agitation and wandering at night. He expressed delusional statements, such as &#x0201c;Everyone is dead, gone, and the times feel different,&#x0201d; prompting his hospitalization. This was the first time that his next of kin confirmed psychotic symptoms. However, the following day, he remembered that his family had taken him to the hospital the previous night and he also remembered what he had said. Date and location orientation were sometimes retained; however, when the MMSE was used, they were not retained and were scored as 9. Head MRI showed no new hemorrhage or infarction (Figure <xref rid="pcn570125-fig-0001" ref-type="fig">1</xref>, right), and EEG was normal.</p><fig position="float" fig-type="Figure" id="pcn570125-fig-0001"><label>Figure 1</label><caption><p>MRI FLAIR images of the patient before and after hospitalization. The left panel shows images at 1 year after the injury, and the right panel shows images on the day before hospitalization.</p></caption><graphic xlink:href="PCN5-4-e70125-g001" position="anchor" id="jats-graphic-3"/></fig><p>Although the symptoms fluctuated, the patient often became agitated, which triggered auditory hallucinations. After the symptoms subsided, he reflected on his experiences. He had been taking 24&#x02009;mg of perospirone hydrochloride hydrate (perospirone) for over a year before hospitalization. Given its prolonged use, we hypothesized that it would no longer be effective. Additionally, previous studies suggest that the effectiveness of perospirone is inferior compared to other second&#x02010;generation antipsychotics.<xref rid="pcn570125-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Therefore, risperidone was initiated after hospitalization, and gradually increased from 0.5 to 2&#x02009;mg over 2.5 weeks, maintaining this dose until discharge (1 month). Upon admission, we considered the possibility of drug&#x02010;induced delirium and discontinued medications deemed unnecessary (brotizolam, trihexyphenidyl hydrochloride, furosemide, and lansoprazole). His symptoms resolved within 1 month. One week after symptom resolution, perospirone was gradually tapered and discontinued over 2 weeks, with no symptom recurrence observed for at least 3 months. Upon symptom resolution, the patient's MMSE score was 26.</p><p>Prescriptions at the time of admission were as follows: perospirone hydrochloride hydrate, 24&#x02009;mg; zonisamide, 300&#x02009;mg; phenytoin, 100&#x02009;mg; sodium valproate, 1000&#x02009;mg; brotizolam 0.25&#x02009;mg; lemborexant 7.5&#x02009;mg; trihexyphenidyl hydrochloride, 6&#x02009;mg; miglitol, 150&#x02009;mg; magnesium oxide, 1320&#x02009;mg; furosemide, 20&#x02009;mg; and lansoprazole, 15&#x02009;mg.</p><p>The final discharge prescriptions were risperidone (2&#x02009;mg), phenytoin (100&#x02009;mg), sodium valproate (1000&#x02009;mg), miglitol (150&#x02009;mg), and magnesium oxide (1320&#x02009;mg).</p></sec><sec sec-type="discussion" id="pcn570125-sec-0060"><title>DISCUSSION</title><p>This patient exhibited disturbances in attention and awareness that developed over a short period and fluctuated in severity throughout the day. However, it did not disturb cognition; therefore, it did not meet the criteria for delirium.<xref rid="pcn570125-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> In addition, the diurnal variation in symptoms suggests that, if considered part of a manic or depressive episode associated with bipolar disorder, the duration was too short to fulfill the diagnostic criteria.<xref rid="pcn570125-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> The patient also experienced hallucinations; however, his delusional statements did not meet the definition of delusions, as they lacked sufficient conviction.<xref rid="pcn570125-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Furthermore, he did not exhibit disorganized speech, grossly disorganized or catatonic behavior, or negative symptoms. Therefore, it did not meet the criteria for schizophrenia.<xref rid="pcn570125-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> This represents an incomplete combination of symptoms.</p><p>Most psychotic symptoms of PDTBI involve delusions (92%) and hallucinations (87%), with persecutory delusions (77%) and auditory hallucinations (92%) being the most common.<xref rid="pcn570125-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> In this case, the patient reported auditory hallucinations, such as &#x0201c;run away,&#x0201d; and exhibited with preparing to escape. However, the symptoms subsided with a gradual increase in risperidone. According to previous case series, antipsychotic medication was highly effective in nearly 90% of cases, whereas other patients responded well to antiepileptic drugs, antidepressants, and lithium.<xref rid="pcn570125-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="pcn570125-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Additionally, a previous study reported that the onset age of PDTBI is 33.4&#x02009;&#x000b1;&#x02009;15.4 years, with a delay of onset of 4.1&#x02009;&#x000b1;&#x02009;6.6 years.<xref rid="pcn570125-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Based on these findings, the present patient deviated significantly from these distributions and initially appeared to have delirium, making it difficult to suspect TBI as the underlying cause. However, the patient's clinical course followed the typical symptomatic and therapeutic course of PDTBI. Previous studies have shown that TBI can lead to the long&#x02010;term development of tau pathology in both humans and animal models.<xref rid="pcn570125-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="pcn570125-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> This is one possible mechanism for late&#x02010;onset PDTBI. Unlike Alzheimer's disease, this process is thought to involve distinct tau lesions.<xref rid="pcn570125-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In this case, the patient's cognitive impairment compared to his pre&#x02010;hospitalization state was temporary and reversible, and he was not diagnosed with dementia, which is consistent with this neuropathology.</p><p>A differential diagnosis that could not be completely ruled out in this case was drug&#x02010;induced psychosis. The patient had been taking 300&#x02009;mg of zonisamide, which causes psychosis,<xref rid="pcn570125-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> daily for 12 years as part of the epilepsy treatment. The disappearance of auditory hallucinations occurred approximately 1 week after increasing risperidone to 2&#x02009;mg and discontinuing zonisamide, making it difficult to determine which intervention was responsible. However, the zonisamide serum concentration at hospitalization was 4.7&#x02009;&#x003bc;g/mL, well below the therapeutic range, making this possibility unlikely. Additionally, several medications (brotizolam, trihexyphenidyl hydrochloride, furosemide, and lansoprazole) were discontinued upon admission. Considering that it took approximately 1 month for the symptoms to resolve, it is unlikely that these medications were the primary cause of the psychotic symptoms. Nevertheless, the possibility of a multidrug potentiation effect cannot be completely ruled out. Similarly, we cannot completely rule out the effects of prior COVID&#x02010;19 infection, as previous studies have reported new&#x02010;onset psychotic disorder in 0.42% of cases following COVID&#x02010;19 infection<xref rid="pcn570125-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>; therefore, it was extremely unlikely, but could be a risk factor.</p></sec><sec sec-type="conclusions" id="pcn570125-sec-0070"><title>CONCLUSION</title><p>Late&#x02010;onset PDTBI can occur long after initial injury, necessitating careful and continuous monitoring. For patients with TBI&#x02010;associated epilepsy, it is advisable to use medications that are less likely to induce psychotic symptoms as side&#x02010;effects.</p></sec><sec id="pcn570125-sec-0080"><title>AUTHOR CONTRIBUTION</title><p>Tomonobu Kato and Takashi Tsujii treated the patient at the hospital, whereas Daiki Mochizuki and Shigeru Nikkuni treated the patient at an outpatient clinic. Tomonobu Kato wrote the manuscript. All authors participated in the discussion, writing, and revisions and read and approved the final version of the manuscript.</p></sec><sec sec-type="COI-statement" id="pcn570125-sec-0100"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no conflict of interest.</p></sec><sec id="pcn570125-sec-0130"><title>ETHICS APPROVAL STATEMENT</title><p>N/A.</p></sec><sec id="pcn570125-sec-0140"><title>PATIENT CONSENT STATEMENT</title><p>The patient provided verbal informed consent and records were made regarding the method and content of the explanation as well as the details of the consent obtained.</p></sec><sec id="pcn570125-sec-0150"><title>CLINICAL TRIAL REGISTRATION</title><p>N/A.</p></sec></body><back><ack id="pcn570125-sec-0090"><title>ACKNOWLEDGMENTS</title><p>We thank the hospital staff for their generous support with the treatment. This study received no funding.</p></ack><sec sec-type="data-availability" id="pcn570125-sec-0120"><title>DATA AVAILABILITY STATEMENT</title><p>N/A.</p></sec><ref-list content-type="cited-references" id="pcn570125-bibl-0001"><title>REFERENCES</title><ref id="pcn570125-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="pcn570125-cit-0001">
<string-name>
<surname>Guan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>. <article-title>Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990&#x02013;2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>BMJ Open</source>. <year>2023</year>;<volume>13</volume>(<issue>10</issue>):<elocation-id>e075049</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2023-075049</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="pcn570125-cit-0002">
<string-name>
<surname>Riggio</surname>
<given-names>S</given-names>
</string-name>. <article-title>Traumatic brain injury and its neurobehavioral sequelae</article-title>. <source>Neurol Clin</source>. <year>2011</year>;<volume>29</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02013;<lpage>47</lpage>vii. <pub-id pub-id-type="doi">10.1016/j.ncl.2010.10.008</pub-id>
<pub-id pub-id-type="pmid">21172569</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="pcn570125-cit-0003">
<string-name>
<surname>Fujii</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>I</given-names>
</string-name>. <article-title>Characteristics of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. <year>2002</year>;<volume>14</volume>(<issue>2</issue>):<fpage>130</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1176/jnp.14.2.130</pub-id>.<pub-id pub-id-type="pmid">11983787</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="pcn570125-cit-0004">
<string-name>
<surname>Ardila</surname>
<given-names>A</given-names>
</string-name>. <article-title>Psychiatric disorders associated with acquired brain pathology</article-title>. <source>Appl Neuropsychol Adult</source>. <year>2019</year>;<volume>26</volume>(<issue>6</issue>):<fpage>591</fpage>&#x02013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1080/23279095.2018.1463224</pub-id>.<pub-id pub-id-type="pmid">30183352</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="pcn570125-cit-0005">
<string-name>
<surname>Jorge</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>RG</given-names>
</string-name>. <article-title>Mood disorders following traumatic brain injury</article-title>. <source>Int Rev Psychiatry</source>. <year>2003</year>;<volume>15</volume>:<fpage>317</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1080/09540260310001606700</pub-id>
<pub-id pub-id-type="pmid">15276953</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="pcn570125-cit-0006">
<string-name>
<surname>Nicholl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>LaFrance</surname>
<given-names>W</given-names>
</string-name>. <article-title>Neuropsychiatric sequelae of traumatic brain injury</article-title>. <source>Semin Neurol</source>. <year>2009</year>;<volume>29</volume>:<fpage>247</fpage>&#x02013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1223878</pub-id>.<pub-id pub-id-type="pmid">19551601</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="pcn570125-cit-0007">
<string-name>
<surname>Fujii</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Psychotic disorder due to traumatic brain injury: analysis of case studies in the literature</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. <year>2012</year>;<volume>24</volume>(<issue>3</issue>):<fpage>278</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1176/appi.neuropsych.11070176</pub-id>.<pub-id pub-id-type="pmid">23037642</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="pcn570125-cit-0008">
<string-name>
<surname>Kim</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Myung</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Suh</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Seong</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>
<given-names>JY</given-names>
</string-name>, et al. <article-title>Clinical approaches to late&#x02010;onset psychosis</article-title>. <source>J Pers Med</source>. <year>2022</year>;<volume>12</volume>(<issue>3</issue>):<elocation-id>381</elocation-id>. <pub-id pub-id-type="doi">10.3390/jpm12030381</pub-id>
<pub-id pub-id-type="pmid">35330384</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="pcn570125-cit-0009">
<string-name>
<surname>Kishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iwata</surname>
<given-names>N</given-names>
</string-name>. <article-title>Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta&#x02010;analysis of randomized controlled trials</article-title>. <source>CNS Drugs</source>. <year>2013</year>;<volume>27</volume>:<fpage>731</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1007/s40263-013-0085-7</pub-id>
<pub-id pub-id-type="pmid">23812802</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0010"><label>10</label><mixed-citation publication-type="miscellaneous" id="pcn570125-cit-0010">American Psychiatric Association. Neurocognitive disorders. In: Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association; <year>2022</year>. <pub-id pub-id-type="doi">10.1176/appi.books.9780890425787.x17_Neurocognitive_Disorders</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0011"><label>11</label><mixed-citation publication-type="miscellaneous" id="pcn570125-cit-0011">
<collab collab-type="authors">American Psychiatric Association</collab>
. <article-title>Bipolar and related disorders</article-title>. In: <article-title>Diagnostic and statistical manual of mental disorders</article-title> (5th ed., text rev.). American Psychiatric Association; <year>2022</year>. <pub-id pub-id-type="doi">10.1176/appi.books.9780890425787.x03_Bipolar_and_Related_Disorders</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0012"><label>12</label><mixed-citation publication-type="miscellaneous" id="pcn570125-cit-0012">
<collab collab-type="authors">American Psychiatric Association</collab>
. <article-title>Schizophrenia spectrum and other psychotic disorders</article-title>. In: <article-title>Diagnostic and statistical manual of mental disorders</article-title> (5th ed., text rev.). American Psychiatric Association; <year>2022</year>. <pub-id pub-id-type="doi">10.1176/appi.books.9780890425787.x02_Schizophrenia_Spectrum</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="pcn570125-cit-0013">
<string-name>
<surname>Edwards</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dash</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Soto</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Moreno&#x02010;Gonzalez</surname>
<given-names>I</given-names>
</string-name>. <article-title>Traumatic brain injury induces Tau aggregation and spreading</article-title>. <source>J Neurotrauma</source>. <year>2020</year>;<volume>37</volume>(<issue>1</issue>):<fpage>80</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2018.6348</pub-id>
<pub-id pub-id-type="pmid">31317824</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="pcn570125-cit-0014">
<string-name>
<surname>Walker</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chapin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Abisambra</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>DeKosky</surname>
<given-names>ST</given-names>
</string-name>. <article-title>Association between single moderate to severe traumatic brain injury and long&#x02010;term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature</article-title>. <source>Acta Neuropathol Commun</source>. <year>2022</year>;<volume>10</volume>(<issue>13</issue>):<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-022-01311-0</pub-id>
<pub-id pub-id-type="pmid">35101132</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="pcn570125-cit-0015">
<string-name>
<surname>Takahata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sahara</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Koga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ichise</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>PET&#x02010;detectable tau pathology correlates with long&#x02010;term neuropsychiatric outcomes in patients with traumatic brain injury</article-title>. <source>Brain</source>. <year>2019</year>;<volume>142</volume>(<issue>10</issue>):<fpage>3265</fpage>&#x02013;<lpage>3279</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awz238</pub-id>.<pub-id pub-id-type="pmid">31504227</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="pcn570125-cit-0016">
<string-name>
<surname>Miyamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kohsaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>T</given-names>
</string-name>. <article-title>Psychotic episodes during zonisamide treatment</article-title>. <source>Seizure</source>. <year>2000</year>;<volume>9</volume>:<fpage>65</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1053/seiz.1999.0368</pub-id>
<pub-id pub-id-type="pmid">10667966</pub-id>
</mixed-citation></ref><ref id="pcn570125-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="pcn570125-cit-0017">
<string-name>
<surname>Taquet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Geddes</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Husain</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Luciano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>6&#x02010;Month neurological and psychiatric outcomes in 236&#x02009;379 survivors of COVID&#x02010;19: a retrospective cohort study using electronic health records</article-title>. <source>Lancet Psychiatry</source>. <year>2021</year>;<volume>8</volume>(<issue>5</issue>):<fpage>416</fpage>&#x02013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(21)00084-5</pub-id>
<pub-id pub-id-type="pmid">33836148</pub-id>
</mixed-citation></ref></ref-list></back></article>